share_log

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

Navidea Biopharmaceuticals收到書面通知,稱紐約證券交易所決心啓動公司股票退市程序;公司董事會將對啓動退市程序的決定提出上訴
Benzinga ·  2023/07/31 16:07

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

Navidea Biopharmaceuticals收到書面通知,稱紐約證券交易所決心啓動公司股票退市程序;公司董事會將對啓動退市程序的決定提出上訴

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論